Prescription to over-the-counter switch: a regulatory perspective.
about
Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische KopfschmerzgesellschNow you see it. Now you don't: fair balance and adequate provision in advertisements for drugs before and after the switch from prescription to over-the-counter.A history of drug advertising: the evolving roles of consumers and consumer protectionImproving the decision-making process for nonprescription drugs: a framework for benefit-risk assessment.From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006-2015: pharmacological perspectives on regulatory decisions.
P2860
Prescription to over-the-counter switch: a regulatory perspective.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Prescription to over-the-counter switch: a regulatory perspective.
@en
Prescription to over-the-counter switch: a regulatory perspective.
@nl
type
label
Prescription to over-the-counter switch: a regulatory perspective.
@en
Prescription to over-the-counter switch: a regulatory perspective.
@nl
prefLabel
Prescription to over-the-counter switch: a regulatory perspective.
@en
Prescription to over-the-counter switch: a regulatory perspective.
@nl
P1476
Prescription to over-the-counter switch: a regulatory perspective.
@en
P2093
P304
P356
10.1016/S0149-2918(98)80015-5
P478
20 Suppl C
P577
1998-01-01T00:00:00Z